We are live on ! Find out more
BSX icon

Boston Scientific

552 hedge funds and large institutions have $31.5B invested in Boston Scientific in 2017 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 180 increasing their positions, 227 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more funds holding in top 10

Funds holding in top 10: 911 (+2)

16% more capital invested

Capital invested by funds: $27.2B → $31.5B (+$4.33B)

13% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 61

0.29% more ownership

Funds ownership: 92.31%92.6% (+0.29%)

0% more call options, than puts

Call options by funds: $39.8M | Put options by funds: $39.8M

1% less funds holding

Funds holding: 556552 (-4)

21% less repeat investments, than reductions

Existing positions increased: 180 | Existing positions reduced: 227

Holders
552
Holders Change
-4
Holders Change %
-0.72%
% of All Funds
13.74%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.27%
New
69
Increased
180
Reduced
227
Closed
61
Calls
$39.8M
Puts
$39.8M
Net Calls
+$34K
Net Calls Change
-$20.9M

BSX Hedge Fund Activity: Q1 2017 in Review

552 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Boston Scientific (BSX) for Q1 2017, worth a combined $31.5B — up 16% from $27.2B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new BSX positions and 61 closed out — a net gain of 8 holders — while 180 added to existing stakes and 227 trimmed.

The largest buyer was BlackRock, adding an estimated $2.23B. The largest seller was Citadel Advisors, cutting an estimated $164M.

  • 552 institutional investors held Boston Scientific (BSX) as of Q1 2017, down from 556 in Q4 2016.
  • Funds reported $31.5B of Boston Scientific stock for Q1 2017, up 16% quarter-over-quarter.
  • 69 funds opened new Boston Scientific positions in Q1 2017 and 61 closed out, a net change of +8 holders.
  • The largest Boston Scientific buyer in Q1 2017 was BlackRock, an estimated $2.23B added.
  • The largest Boston Scientific seller in Q1 2017 was Citadel Advisors, an estimated $164M sold.

Based on aggregated 13F filings for Q1 2017.